Insights

Insight In boardrooms around the world, change management is still often treated as an “afterthought” – something to “layer on” after the technology is selected, the budget approved and the plan in motion. But in today’s...

White Paper Is Real-world Evidence (RWE) the new gold standard for data generation? Our latest whitepaper investigates how RWE is transforming the pharma industry, offering a future-proof, cost-effective approach to drug approval and market access. While Randomised...

Insight Expecting a Maximo team to become OpenShift experts can be a challenging approach. Specialised tools require specialised expertise and investing in a dedicated OpenShift team ensures both technologies deliver their full value without compromise. This...

Insight Digital transformation is revolutionising life sciences labs with AI, automation, and robotics, boosting efficiency and discovery. But can labs truly operate without humans? Explore the future of autonomous labs, the challenges ahead, and why human-machine...

Insight Pharma companies must decide whether to in-source AI-powered content creation for control and compliance or outsource for speed and expertise. Explore how Gen AI is reshaping HCP content workflows, the risks and benefits of different...

Insight Digital therapeutics are transforming healthcare by turning smartphones and wearables into personalised treatment tools, breaking down access barriers, and proving what real-time data can deliver. Better outcomes—anytime, anywhere.